颈动脉内膜剥脱联合锁骨下动脉-颈动脉旁路术的安全性与耐久性
本研究回顾性分析37例因严重颈内动脉狭窄合并近端颈总动脉或锁骨下动脉闭塞行颈动脉内膜剥脱(CEA)联合锁骨下动脉-颈动脉旁路移植(CSBG)的患者,30天卒中/死亡率为5.4%,5年主要通畅率85%,免于卒中率97%,与单纯CSBG组(28例)相比围术期卒中/死亡及晚期通畅率无差异,提示联合手术安全耐久。
要点
- 联合CEA/CSBG的30天卒中/死亡率为5.4%,症状即刻缓解率100%。
- 5年主要通畅率85%,免于卒中率97%,无卒中生存率78%。
- 与单纯CSBG相比,围术期卒中/死亡及晚期通畅率无显著差异。
核心结论
- 同期CEA联合CSBG安全且耐久,围术期卒中/死亡及晚期通畅率与单纯CSBG无显著差异。
研究设计与样本
- 回顾性分析同一机构三十年间接受同期CEA联合CSBG的37例患者电子病历,采用Kaplan-Meier法评估晚期通畅率及卒中相关结局。
- 与既往发表的同组单纯CSBG(28例)数据进行比较。
主要发现
- 37例联合手术患者平均年龄64岁(范围45-81岁),手术指征包括手臂缺血12例(32%)、半球性TIA或卒中15例(41%)、椎基底动脉供血不足4例(11%)、症状性锁骨下动脉窃血10例(27%)、无症状颈总动脉闭塞伴严重颈内动脉狭窄6例(16%)。
- 30天围术期卒中/死亡率为5.4%(1例卒中,1例死亡),症状即刻缓解率100%,症状复发率2.7%(TIA)。
- CEA和CSBG的粗通畅率为92%;1、2、3、4、5年主要通畅率分别为100%、96%、96%、96%、85%;免于卒中率分别为97%、97%、97%、97%、97%;无卒中生存率分别为94%、94%、87%、82%、78%。
- 与单纯CSBG组(28例)比较,围术期卒中(2.7% vs 0%)、围术期死亡(2.7% vs 2.8%)及晚期通畅率(92% vs 96%)均无差异。
临床怎么用
- 对于严重颈内动脉狭窄合并近端颈总动脉或锁骨下动脉闭塞且具备相应指征的患者,可考虑同期行CEA联合CSBG。
- 术后需通过临床和双功超声监测桥血管及CEA部位的通畅性。
局限性
- 回顾性单中心研究,样本量小(37例联合手术),部分亚组事件数少。
- 与单纯CSBG的比较为历史数据对照,非随机对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Concomitant carotid endarterectomy (CEA; for severe internal carotid artery stenosis) with carotid-subclavian bypass grafting (CSBG; for proximal common carotid artery or subclavian artery occlusion) is rarely used. Only a few studies have been reported. This report analyzed early and late clinical outcomes of the largest study to date of the combined procedures in our institution. METHODS: Electronic medical records of patients who had concomitant CEA with CSBG during three decades were analyzed. Indications for surgery were arm ischemia, neurologic events, and clinical subclavian steal. Early (30 days) perioperative complications (stroke, death, and others) and late complications (stroke, death) were recorded. Kaplan-Meier analysis was used to estimate late graft/CEA primary patency, freedom from stroke, and stroke-free survival rates. Graft patency was determined clinically and confirmed using duplex ultrasound. Outcomes were compared with previously published data on isolated CSBG by the same group. RESULTS: There were 37 combined procedures analyzed. Mean age was 64 years (range, 45-81 years). Indications for surgery were arm ischemia in 12 (32%), hemispheric transient ischemic attack or stroke in 15 (41%), vertebrobasilar insufficiency in 4 (11%), symptomatic subclavian steal in 10 (27%), and asymptomatic common carotid artery occlusion with severe internal carotid artery stenosis in 6 (16%). The 30-day perioperative (stroke and death) rate was 5.4% (one stroke and one death). Immediate symptom relief was noted in 100%, with 2.7% (transient ischemic attack) symptom recurrence. The crude patency rate of both CEA and CSBG was 92%. At 1 year, 2 years, 3 years, 4 years, and 5 years, respectively, primary patency rates were 100%, 96%, 96%, 96%, and 85%; freedom from stroke rates were 97%, 97%, 97%, 97%, and 97%; and stroke-free survival rates were 94%, 94%, 87%, 82%, and 78%. When these outcomes were compared with the isolated CSBG group alone (28 patients), there was no difference in perioperative stroke (2.7% for concomitant CEA/CSBG vs 0% for isolated CSBG), perioperative death (2.7% vs 2.8%), or late patency rates (92% vs 96%). CONCLUSIONS: Concomitant CEA/CSBG is safe and durable. There was no significant difference in perioperative stroke/death or late patency rates compared with isolated CSBG.
引用
- AbuRahma AF, Lee A, Davis E, et al. Safety and durability of concomitant carotid endarterectomy with carotid-subclavian bypass grafting. J Vasc Surg. 2020. PMID: 32361068. doi:10.1016/j.jvs.2020.03.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。